NET PROFIT (x1000 SEK)
EMPLOYEES
Biobad Scand. AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-1
|
-33
|
-5 |
| EBITDA |
-1
|
-33
|
-5 |
| Total assets |
28
|
30
|
63 |
| Current assets |
28
|
30
|
63 |
| Current liabilities |
3
|
4
|
3 |
| Equity capital |
25
|
26
|
60 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.3%
|
86.7%
|
95.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-3.6%
|
-110.0%
|
-7.9% |
| Current ratio |
933.3%
|
750.0%
|
2100% |
| Return on equity (ROE) |
-4.0%
|
-126.9%
|
-8.3% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.